Emerging therapeutic options for sporadic inclusion body myositis
Lindsay N Alfano, Linda P Lowes Nationwide Children’s Hospital, Center for Gene Therapy, Columbus, OH, USA Abstract: Sporadic inclusion body myositis is the most common inflammatory muscle disorder preferentially affecting males over the age of 40 years. Progressive muscle weakness of th...
Main Authors: | Alfano LN, Lowes LP |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2015-09-01
|
Series: | Therapeutics and Clinical Risk Management |
Online Access: | https://www.dovepress.com/emerging-therapeutic-options-for-sporadic-inclusion-body-myositis-peer-reviewed-article-TCRM |
Similar Items
-
Development of new therapeutic strategies for sporadic Inclusion Body Myositis
by: Miller, A. D.
Published: (2015) -
Sporadic inclusion body myositis in the rheumatology clinic
by: Fernando Henrique Carlos de Souza, et al.
Published: (2020-01-01) -
Mitochondrial Biology in Sporadic Inclusion Body Myositis
by: Shabrokh, Elika
Published: (2014) -
Investigating novel therapeutic approaches for sporadic inclusion body myositis (sIBM)
by: Ahmed, M.
Published: (2012) -
The role of emerin in the pathogenesis of sporadic inclusion body myositis
by: Marini Bettolo, Chiara
Published: (2015)